Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Gold's Time to Shine: A Solid Investment Opportunity

Click here to access the report.
Jeff Nielson | July 19, 2023 |

Analyst Upgrade Ignites Duchenne's Muscular Dystrophy Research Firm's Shares

Solid Biosciences' shares are up by more than 40% today after Chardan Capital Markets upgraded the firm's shares from "neutral" to "buy" and raised its price target from $7.50 to $10.00/share. Duchenne muscular dystrophy (DMD) research firm Solid Biosciences ...
Streetwise Reports | August 20, 2019 |

Buzz on the Bullboards: A briefing of the hottest & latest trends

Canada’s main stock index posted a solid rebound this week as energy stocks climbed along with the price of oil. Gains were capped by declines seen in the health care, and telecom sectors.
Jonathon Brown | November 24, 2022 |

Biopharma to Test Immunity Activator in Advanced Solid Cancers

The company's plans for and approach to one of its most advanced drug candidates are discussed in an H.C. Wainwright & Co. report. In a Dec. 12 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that BioXcel Therapeutics Inc. (BTAI:NASDAQ) plans to ...
Streetwise Reports | December 19, 2019 |

Westhaven’s robust economics are a solid foundation to expand gold-silver inventory

In the heart of British Columbia, a new study has illuminated a high-grade gold project with immense potential right off a highway. The findings indicate a compelling low-cost, high-margin opportunity that has captured the attention of investors seeking exceptional return...
Research | July 24, 2023 |

A Near Perfect Opportunity: Identifying a Solid Gold Story at its Beginning

Having a piece of highly prospective property is a good start for a junior resource company. Tocvan Resources ( TOC.CC ), after Mark Smethurst, the company’s COO, looked at over 150 possible properties, found a property with high gold and silver potential ...
Jay Currie | September 3, 2020 |

Interim Data Indicate Multiantigen Cell Therapy in Solid Tumors 'Just Might Work'

The immuno-oncology company's findings are reviewed in a ROTH Capital Partners report. In a July 22 research note, ROTH Capital Partners analyst Tony Butler reported that "encouraging data" from Marker Therapeutics Inc.'s (MRKR:NASDAQ) Phase I trial, TACTO...
Streetwise Reports | July 24, 2019 |

Gold Miner Shows Solid Production, Minimal COVID-19 Impacts in Q1/20

Great Panther Mining's activities during the year's first quarter are summarized in a ROTH Capital Partners report. In an April 13 research note, ROTH Capital Partners analyst Jake Sekelsky reported that Great Panther Mining Ltd. (GPR:TSX; GPL:NYSE.American...
Streetwise Reports | April 17, 2020 |

Coverage Initiated on 'Solid Platform Company' with Sanofi Partnership

The reasons why this biopharma makes a compelling investment are outlined in a ROTH Capital Partners report. In a June 18 research note, analyst Tony Butler reported that ROTH Capital Partners initiated coverage on Translate Bio (TBIO:NASDAQ) , in advan...
Streetwise Reports | June 27, 2019 |

Energy Infrastructure Firm Posts Solid Q1/19, Remains 'Poised to Outperform'

A recap of this Texas company's first quarter was provided in a Raymond James report. In an April 18, 2019 research note, Raymond James analyst Justin Jenkins reported that Kinder Morgan Inc. (KMI:NYSE) had a "mostly quiet," Q1/19, showing "strong performance on ...
Streetwise Reports | May 1, 2019 |
1 2 3 4 5 6 7 8 9 10 ...